[EN] ATTENUATION OF NEURODEGENERATION ASSOCIATED WITH PARKINSON'S DISEASE BY INHIBITION OF THE DOPAMINE D3 RECEPTOR IN CD4+ T CELLS<br/>[FR] ATTÉNUATION DE LA NEURODÉGÉNÉRESCENCE ASSOCIÉE À LA MALADIE DE PARKINSON PAR INHIBITION DU RÉCEPTEUR DOPAMINERGIQUE DU TYPE D3 DANS LES LYMPHOCYTES T CD4+
申请人:FUNDACIÓN CIENCIA PARA LA VIDA
公开号:WO2017168390A2
公开(公告)日:2017-10-05
Method for preventing or treating neurodegenerative diseases, based in treating in vitro or ex vivo CD4+ T cells obtained from a subject, with a dopamine D3 (D3R) receptor inhibitor compound, and reincorporating the pre-treated CD4+ T cells to the subject, in an autologous transplant.